Emma Walsh
Associate in our Antitrust & Competition practice, based in London.
Emma advises on all areas of U.K. and EU competition law. She advises clients in merger control and foreign direct investment reviews, as well as competition litigation, cartel investigations, dawn raids and abuse of dominance proceedings. Emma represents clients in the Competition Appeal Tribunal, the High Court, the Court of Appeal, and the U.K. Supreme Court, and has experience defending clients against investigations by the competition authorities, including the Competition and Markets Authority and the European Commission. Emma represents clients across numerous industries including retail, pharmaceuticals, animal health, sports, telecommunications, financial services and construction.
Experience
- Roche on its $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
Prior to joining Davis Polk, Emma’s experience includes advising:
- A pharmaceutical company in connection with challenges to Competition and Markets Authority (CMA) search warrants at the High Court and the Court of Appeal. This was the first challenge to a CMA search warrant under s. 28 of the Competition Act 1998
- A pharmaceutical company in relation to investigations by the CMA into alleged excessive pricing and pay-for-delay arrangements
- On a European Commission cartel investigation
- Various clients on dawn raids conducted by the CMA and the European Commission
Insights
Education
Qualifications and admissions
- England and Wales